Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             242 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case-control study of diet and lung cancer in Kerala, South India 1995
12 1-2 p. 115-
1 p.
artikel
2 A case of endobronchial carcinoid tumour treated with intratumoral injection of absolute alcohol 1995
12 1-2 p. 131-
1 p.
artikel
3 A case of von Recklinghausen's disease and concurrent lung cancer with neurofibroma of the intrathoracic vagus nerve 1995
12 1-2 p. 132-
1 p.
artikel
4 A case report of granular cell tumor of the bronchus 1995
12 1-2 p. 138-
1 p.
artikel
5 A clinical therapeutic results on small cell lung cancer 1995
12 1-2 p. 159-
1 p.
artikel
6 Activity of docetaxel (Taxotere) in small cell lung cancer 1995
12 1-2 p. 146-
1 p.
artikel
7 A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil 1995
12 1-2 p. 145-
1 p.
artikel
8 A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes 1995
12 1-2 p. 120-
1 p.
artikel
9 A human small cell lung carcinoma cell line, resistant to 4′-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I 1995
12 1-2 p. 144-145
2 p.
artikel
10 All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer 1995
12 1-2 p. 121-
1 p.
artikel
11 Alpha-amylase in resectable lung cancer 1995
12 1-2 p. 140-
1 p.
artikel
12 Alpha interferon, leucovorin, and 5-fluorouracil (ALF) in advanced cancer: Results of a dose-finding study and evidence of activity in non-small cell lung cancer 1995
12 1-2 p. 147-
1 p.
artikel
13 Alteration in length of telomeric repeats in lung cancer 1995
12 1-2 p. 122-
1 p.
artikel
14 Alternating irradiation and chemotherapy in Stage III A and B nonsmall cell lung cancer: Report of a cancer and leukemia group B phase II study 8636 1995
12 1-2 p. 156-
1 p.
artikel
15 Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer 1995
12 1-2 p. 120-
1 p.
artikel
16 Analysis of lectin affinity profiles in A case of adenocarcinoma of the lung associated with elevated alpha-fetoprotein in serum and sputum 1995
12 1-2 p. 139-
1 p.
artikel
17 Analysis of urinary fibronectin (UFN) using human lung cancer cells transplanted into nude mice 1995
12 1-2 p. 120-
1 p.
artikel
18 Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inlet 1995
12 1-2 p. 135-
1 p.
artikel
19 Announcements 1995
12 1-2 p. 161-162
2 p.
artikel
20 An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer 1995
12 1-2 p. 151-
1 p.
artikel
21 Antitumor effect of AO-90, methionine-free intravenous amino acid solution, given by total parenteral nutrition in combination with 5-fluorouracil and mitomycin C in Sato lung carcinoma-bearing rats 1995
12 1-2 p. 123-
1 p.
artikel
22 A Phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors 1995
12 1-2 p. 148-
1 p.
artikel
23 A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma 1995
12 1-2 p. 153-
1 p.
artikel
24 A prospective randomized clinical trial comparing preventive and conventional use of rhG-CSF in lung cancer patients receiving chemotherapy 1995
12 1-2 p. 143-
1 p.
artikel
25 A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer 1995
12 1-2 p. 156-
1 p.
artikel
26 A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans 1995
12 1-2 p. 125-
1 p.
artikel
27 A randomized controlled postoperative adjuvant chemotherapy trial of CDDP + VDS + UFT and UFT alone in comparison with operation only for non-small cell lung carcinomas — Second study 1995
12 1-2 p. 147-148
2 p.
artikel
28 A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer 1995
12 1-2 p. 150-
1 p.
artikel
29 Asbestos exposure and the risk of lung cancer in a general urban population 1995
12 1-2 p. 114-
1 p.
artikel
30 Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma 1995
12 1-2 p. 133-
1 p.
artikel
31 Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: Comparison with CT scan 1995
12 1-2 p. 129-130
2 p.
artikel
32 A study of autopsied lung cancer cases among retired workers of the Okuno-jima poison gas factory 1995
12 1-2 p. 115-
1 p.
artikel
33 A study of thymidine kinase activity in lung cancer tissue 1995
12 1-2 p. 127-128
2 p.
artikel
34 A study on nutritional and immunological status during lung cancer therapy 1995
12 1-2 p. 133-134
2 p.
artikel
35 Basic and clinical studies on serum cytokeratin 19 fragment assay using centocorR CYFRA 21-1 kit in patients with lung cancer 1995
12 1-2 p. 128-
1 p.
artikel
36 Benign and malignant salivary gland-type mixed tumors of the lung: Clinicopathologic and immunohistochemical study of eight cases 1995
12 1-2 p. 140-
1 p.
artikel
37 Bilateral Pancoast syndrome in a patient with metachronous primary lung cancer 1995
12 1-2 p. 129-
1 p.
artikel
38 Biopsy Interpretation of the Lung Aisner, Seena C.
1995
12 1-2 p. 109-110
2 p.
artikel
39 Bronchoscopic findings of extramural lung cancer invading the subepithelium or submucosa Gemma, Akihiko
1995
12 1-2 p. 35-44
10 p.
artikel
40 Carboplatin combined etoposide in the treatment of lung cancer 1995
12 1-2 p. 152-
1 p.
artikel
41 Carboplatin for small cell lung cancer: Progress toward greater efficacy and reduced toxicity 1995
12 1-2 p. 147-
1 p.
artikel
42 Case-Control study for lung cancer and cigarette smoking in Osaka, Japan: Comparison with the results from Western Europe 1995
12 1-2 p. 114-
1 p.
artikel
43 Case-control study of residential radon and lung cancer in Winnipeg, Manitoba, Canada 1995
12 1-2 p. 116-
1 p.
artikel
44 c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties 1995
12 1-2 p. 124-
1 p.
artikel
45 Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: An autopsy study 1995
12 1-2 p. 118-
1 p.
artikel
46 Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6 1995
12 1-2 p. 125-126
2 p.
artikel
47 Chemotherapy vs supportive care in advanced non-small-cell lung cancer: Results of a meta-analysis of the literature 1995
12 1-2 p. 145-
1 p.
artikel
48 Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer: Limited activity of an aggressive chemotherapy regimen 1995
12 1-2 p. 155-
1 p.
artikel
49 Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: A randomized phase III study 1995
12 1-2 p. 146-147
2 p.
artikel
50 Cisplatin-5-fluorouracil in small cell lung cancer. A phase II study in 109 patients 1995
12 1-2 p. 144-
1 p.
artikel
51 Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: Preliminary report of a French multicentre phase II trial 1995
12 1-2 p. 154-
1 p.
artikel
52 Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: A randomized placebo-controlled, double-blind phase III study of the cancer and leukemia group B 1995
12 1-2 p. 153-
1 p.
artikel
53 c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung 1995
12 1-2 p. 154-
1 p.
artikel
54 Clinical effects and safety of granisetron administration against CDDP chemotherapy in lung cancer 1995
12 1-2 p. 145-146
2 p.
artikel
55 Clinical features of cavitary lung cancer 1995
12 1-2 p. 132-
1 p.
artikel
56 Clinical usefulness of human cytokeratin 19 fragment (CYFRA 21-1) as serum tumor marker for lung cancer 1995
12 1-2 p. 139-
1 p.
artikel
57 Cohort mortality and nested case-control study of lung cancer among structural pest control workers in Florida (United States) 1995
12 1-2 p. 117-
1 p.
artikel
58 Combination chemotherapy and radiation therapy in lung cancer 1995
12 1-2 p. 156-
1 p.
artikel
59 Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer 1995
12 1-2 p. 143-
1 p.
artikel
60 Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: A phase II study in stage IIIB-IV non-small cell lung cancer 1995
12 1-2 p. 151-
1 p.
artikel
61 Combined treatment in superior sulcus tumors 1995
12 1-2 p. 157-
1 p.
artikel
62 Comparison of clinical neurological function and CT response during chemotherapy for initial brain metastasis from small cell lung cancer 1995
12 1-2 p. 140-
1 p.
artikel
63 Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases 1995
12 1-2 p. 134-135
2 p.
artikel
64 Constitutive c-myc overexpression and P1 P2 promoter shift in a small cell lung cancer cell line 1995
12 1-2 p. 126-
1 p.
artikel
65 Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small cell lung cancer cell line 1995
12 1-2 p. 122-
1 p.
artikel
66 Contemporary situation of screening and primary prevention in control of lung cancer 1995
12 1-2 p. 119-
1 p.
artikel
67 Contribution of cadmium in cigarettes to lung cancer: An evaluation of risk assessment methodologies 1995
12 1-2 p. 116-
1 p.
artikel
68 Correlating exposure to environmental tobacco smoke exposure with increased incidence of lung cancer in non smokers: Is cotinine a valid marker? 1995
12 1-2 p. 116-117
2 p.
artikel
69 Correlation between thin-section CT and histopathological structure in pulmonary adenocarcinoma. 2 Immunohistochemistry of type 4 collagen and laminin in basement membrane 1995
12 1-2 p. 132-
1 p.
artikel
70 Cuneo Lung Cancer Study Group First International Lung Cancer Conference: Non-small cell lung cancer: Open questions and controversies Buccheri, Gianfranco
1995
12 1-2 p. 105-108
4 p.
artikel
71 Cyclin D1 overexpression vs. retinoblastoma inactivation: Implications for growth control evasion in non-small cell and small cell lung cancer 1995
12 1-2 p. 123-
1 p.
artikel
72 CYFRA 21-1 in lung cancer: Comparison with CEA, CA 125, SCC and NSE serum levels 1995
12 1-2 p. 134-
1 p.
artikel
73 Cytogenetic findings in primary non-small cell lung cancer 1995
12 1-2 p. 124-
1 p.
artikel
74 Declining FEV1 and chronic productive cough in cigarette smokers: A 25- year prospective study of lung cancer incidence in Tecumsch, Michigan 1995
12 1-2 p. 113-114
2 p.
artikel
75 Detection of lymph node metastases in lung cancer: Comparison of 131I-Anti-CEA-Anti-CA 19-9 immunoscintigraphy versus computed tomography 1995
12 1-2 p. 128-129
2 p.
artikel
76 Detection of resistance proteins in matched primary lung tumors and lymph node metastases 1995
12 1-2 p. 127-
1 p.
artikel
77 DNA polymerase α as an independent prognostic parameter in non-small cell lung cancer — an immunohistochemical study 1995
12 1-2 p. 137-
1 p.
artikel
78 Docetaxel (TaxotereR) is active in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group (ECTG) 1995
12 1-2 p. 148-
1 p.
artikel
79 Dominated and resistant subpopulation causes regrowth after response to 1,3-Bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice 1995
12 1-2 p. 150-
1 p.
artikel
80 Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer 1995
12 1-2 p. 151-
1 p.
artikel
81 Early Phase II clinical study of KW-2307 in patients with lung cancer 1995
12 1-2 p. 152-
1 p.
artikel
82 Editorial Board 1995
12 1-2 p. IFC-
1 p.
artikel
83 Effect of inhaled indomethacin for bronchorrhea in a case of bronchioloalveolar carcinoma 1995
12 1-2 p. 129-
1 p.
artikel
84 Effect of the dihydropyridine dexniguldipine on the epidermal growth factor-stimulated proliferation of human lung cancer cell lines 1995
12 1-2 p. 124-
1 p.
artikel
85 Effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on small cell lung cancer cells 1995
12 1-2 p. 152-
1 p.
artikel
86 Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study 1995
12 1-2 p. 144-
1 p.
artikel
87 Environmental tobacco smoke and lung cancer in nonsmoking women: A multicenter study 1995
12 1-2 p. 113-
1 p.
artikel
88 Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, GLL-1, producing carcinoembryonic antigen (CEA) and CA19-9 Mitsuhashi, Norio
1995
12 1-2 p. 13-24
12 p.
artikel
89 Establishment of a new lung sarcoma cell line from a human lung carcinosarcoma 1995
12 1-2 p. 120-121
2 p.
artikel
90 Establishment of anti-idiotype monoclonal antibodies (Ab2β) for specific and active immunotherapy in lung cancer patients 1995
12 1-2 p. 127-
1 p.
artikel
91 Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer 1995
12 1-2 p. 151-
1 p.
artikel
92 Etoposide in the treatment of elderly/poor-prognosis patients with small-cell lung cancer 1995
12 1-2 p. 147-
1 p.
artikel
93 Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: A prospective randomized phase III trial 1995
12 1-2 p. 146-
1 p.
artikel
94 Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: Results of a multicenter trial 1995
12 1-2 p. 134-
1 p.
artikel
95 Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients Tammilehto, L.
1995
12 1-2 p. 25-34
10 p.
artikel
96 Experimental evaluation of combination chemotherapy with UFT and cisplatin for the lung cancer 1995
12 1-2 p. 149-
1 p.
artikel
97 Exposure and disposition in the development of lung cancer 1995
12 1-2 p. 119-
1 p.
artikel
98 Exposure to radon progeny, tobacco use and lung cancer in a case-control study in southern China 1995
12 1-2 p. 118-
1 p.
artikel
99 Exposure to stainless steel welding fumes and lung cancer: A meta-analysis 1995
12 1-2 p. 118-119
2 p.
artikel
100 Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization 1995
12 1-2 p. 123-124
2 p.
artikel
101 Expression in lung tumors and genetic mapping of the novel murine protein kinase C3 1995
12 1-2 p. 126-
1 p.
artikel
102 Expression of the glutathione S-transferases in human lung carcinoma 1995
12 1-2 p. 125-
1 p.
artikel
103 Expression of the multidrug resistance gene (MDR1) in non-small cell lung cancer 1995
12 1-2 p. 127-
1 p.
artikel
104 Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung 1995
12 1-2 p. 121-
1 p.
artikel
105 External radiotherapy for Pancoast tumor 1995
12 1-2 p. 147-
1 p.
artikel
106 Fatal pulmonary toxicity following oral etoposide therapy Dajczman, Esther
1995
12 1-2 p. 81-86
6 p.
artikel
107 Fine needle aspiration diagnosis of benign metastasizing leiomyoma of the lung: A case report 1995
12 1-2 p. 140-
1 p.
artikel
108 Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase 1995
12 1-2 p. 129-
1 p.
artikel
109 Future directions in the treatment of non-small cell lung cancer 1995
12 1-2 p. 159-
1 p.
artikel
110 Genesis of squamous cell lung carcinoma: Sequential changes of proliferation, DNA ploidy, and p53 expression 1995
12 1-2 p. 127-
1 p.
artikel
111 Genetic component of lung cancer: Cohort study of twins 1995
12 1-2 p. 116-
1 p.
artikel
112 Glucocorticoid responsive ACTH secreting bronchial carcinoid tumours contain high concentrations of glucocorticoid receptors 1995
12 1-2 p. 136-
1 p.
artikel
113 Glucose-induced thermogenesis in patients with small cell lung carcinoma. The effect of acute β-adrenergic inhibition 1995
12 1-2 p. 136-137
2 p.
artikel
114 Higher lung cancer rates in young women than young men: Tasmania, 1983 to 1992 1995
12 1-2 p. 117-
1 p.
artikel
115 Histology and smoking history of lung cancer cases and implications for prevention in Thailand 1995
12 1-2 p. 118-
1 p.
artikel
116 5-HT(1D) receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma 1995
12 1-2 p. 120-
1 p.
artikel
117 Human evidence: Lung cancer mortality risk from chrysotile exposure 1995
12 1-2 p. 115-116
2 p.
artikel
118 IASLC calendar 1995
12 1-2 p. 111-112
2 p.
artikel
119 Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony- stimulating factor: A phase I study with apparent activity in non-small-cell lung cancer 1995
12 1-2 p. 142-143
2 p.
artikel
120 Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer 1995
12 1-2 p. 138-
1 p.
artikel
121 Immunohistochemical study of cathepsin B: Prognostic significance in human lung cancer 1995
12 1-2 p. 128-
1 p.
artikel
122 Immunoscintigraphy using 111In-Labelled F(AB′)2 fragments of anticarcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma 1995
12 1-2 p. 129-
1 p.
artikel
123 Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor 1995
12 1-2 p. 142-
1 p.
artikel
124 Inconsistency between workplace and spousal studies of environmental tobacco smoke and lung cancer 1995
12 1-2 p. 113-
1 p.
artikel
125 Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA B non-small cell lung cancer 1995
12 1-2 p. 150-
1 p.
artikel
126 Infusional cisplatin and etoposide in the treatment of stage III-B and IV non-small cell lung cancer: A well tolerated regimen 1995
12 1-2 p. 156-
1 p.
artikel
127 Inhibition of growth of human small cell lung cancer by bromocriptine 1995
12 1-2 p. 148-
1 p.
artikel
128 In survival curves is the P-value enough? Marino, Pietro
1995
12 1-2 p. 87-89
3 p.
artikel
129 Integrin expression and ability to adhere to extracellular matrix proteins and endothelial cells in human lung cancer lines 1995
12 1-2 p. 119-
1 p.
artikel
130 Intensive combined-modality therapy in small cell lung cancer 1995
12 1-2 p. 157-
1 p.
artikel
131 Japanese doctors' preferred treatment choices for their hypothetical non-small cell lung cancer: How they would wish to be treated 1995
12 1-2 p. 159-160
2 p.
artikel
132 Karyotypic abnormalities in adenocarcinomas of the lung 1995
12 1-2 p. 126-
1 p.
artikel
133 Karyotypic characterization of bronchial large cell carcinomas 1995
12 1-2 p. 127-
1 p.
artikel
134 K-ras gene mutations: An unfavorable prognostic marker in stage I lung adenocarcinoma 1995
12 1-2 p. 137-138
2 p.
artikel
135 K-ras gene point mutation: A stable tumor marker in non-small cell lung carcinoma 1995
12 1-2 p. 122-123
2 p.
artikel
136 Less initial rejoining of X-ray-induced DNA double-strand breaks in cells of a small cell (U-1285) compared to a large cell (U-1810) lung carcinoma cell line 1995
12 1-2 p. 123-
1 p.
artikel
137 Lithium oxybutyrate administration in lung cancer patients to improve results in early postoperative period 1995
12 1-2 p. 141-
1 p.
artikel
138 Lung cancer 1995
12 1-2 p. 158-
1 p.
artikel
139 Lung cancer-associated keratin 19 fragments: Development and biochemical characterisation of the new serum assay Enzymun-TestR CYFRA 21-1 1995
12 1-2 p. 121-
1 p.
artikel
140 Lung cancer - Development, diagnosis, therapy, prognosis 1995
12 1-2 p. 159-
1 p.
artikel
141 Lung cancer mortality among asbestos textile workers: A review and update 1995
12 1-2 p. 116-
1 p.
artikel
142 Lung cancer risk and welding — Preliminary results from an ongoing case-control study 1995
12 1-2 p. 118-
1 p.
artikel
143 Miliary mesothelioma 1995
12 1-2 p. 131-
1 p.
artikel
144 Mitomycin C etoposide and vinorelbine (MEV II) in the treatment of metastatic stage IV non small cell lung cancer 1995
12 1-2 p. 149-
1 p.
artikel
145 Modulation of endothelial cell permeability by lung carcinoma cells: A potential mechanism of malignant pleural effusion formation 1995
12 1-2 p. 121-
1 p.
artikel
146 Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines 1995
12 1-2 p. 119-
1 p.
artikel
147 Multimodality therapy for non-small-cell lung cancer 1995
12 1-2 p. 158-
1 p.
artikel
148 Multiple NF-I-site binding factors associated with different cell-types of human lung carcinomas 1995
12 1-2 p. 126-
1 p.
artikel
149 Neo-adjuvant chemotherapy for non-small cell locally advanced bronchogenic cancer 1995
12 1-2 p. 155-
1 p.
artikel
150 Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer 1995
12 1-2 p. 156-
1 p.
artikel
151 Nonoperative management of non-small cell lung cancer: The current Cancer and Leukemia Group B experience 1995
12 1-2 p. 158-
1 p.
artikel
152 NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis 1995
12 1-2 p. 130-
1 p.
artikel
153 Oat cell carcinoma of the lung in patients with CLL 1995
12 1-2 p. 138-
1 p.
artikel
154 Patterns of care and survival in non small cell lung cancer: 15 years' experience in a general hospital 1995
12 1-2 p. 160-
1 p.
artikel
155 Percutaneous computed tomography-guided fine needle brachy-therapy of pulmonary malignancies 1995
12 1-2 p. 136-
1 p.
artikel
156 p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas 1995
12 1-2 p. 122-
1 p.
artikel
157 Phase I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients 1995
12 1-2 p. 149-
1 p.
artikel
158 Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer 1995
12 1-2 p. 153-154
2 p.
artikel
159 Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer 1995
12 1-2 p. 152-
1 p.
artikel
160 Phase II study of fotemustine in untreated inoperable non-small-cell lung cancer 1995
12 1-2 p. 147-
1 p.
artikel
161 Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer 1995
12 1-2 p. 154-
1 p.
artikel
162 Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer Miller, Antonius A.
1995
12 1-2 p. 59-65
7 p.
artikel
163 Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer: An Eastern Cooperative Oncology Group study 1995
12 1-2 p. 155-
1 p.
artikel
164 Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer 1995
12 1-2 p. 152-153
2 p.
artikel
165 Physical fitness of patients with small cell lung cancer 1995
12 1-2 p. 128-
1 p.
artikel
166 Physical map of small cell lung cancer deletion region on short arm of human chromosome 3 (3p13–22) based on radiation fusion hybrid analysis 1995
12 1-2 p. 124-
1 p.
artikel
167 Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer 1995
12 1-2 p. 153-
1 p.
artikel
168 Platinum-based chemotherapy in non-small cell lung cancer: The experience of the European Organization for the Research and Treatment of Cancer 1995
12 1-2 p. 146-
1 p.
artikel
169 Pleural dissemination in non-small cell lung cancer: Results of radiological evaluation and surgical treatment 1995
12 1-2 p. 130-
1 p.
artikel
170 Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection 1995
12 1-2 p. 141-
1 p.
artikel
171 Predictive value of exercise of testing in the evaluation of high risk patients prior to lung resection 1995
12 1-2 p. 131-
1 p.
artikel
172 Pretreatment natural history of small cell lung cancer presenting as a solitary pulmonary nodule 1995
12 1-2 p. 134-
1 p.
artikel
173 Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop Battey, James F.
1995
12 1-2 p. 91-103
13 p.
artikel
174 Prognosis and long-term survival of non-resected non-small-cell lung cancer 1995
12 1-2 p. 133-
1 p.
artikel
175 Prognostic factors for survival interminal lung cancer patients 1995
12 1-2 p. 135-136
2 p.
artikel
176 Prognostic factors in lung cancer: Tables and comments 1995
12 1-2 p. 133-
1 p.
artikel
177 Prognostic factors of small-cell bronchial carcinoma 1995
12 1-2 p. 133-
1 p.
artikel
178 Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma 1995
12 1-2 p. 123-
1 p.
artikel
179 Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: A prospective study 1995
12 1-2 p. 140-141
2 p.
artikel
180 Prognostic value of increased lung tumor tissue cathepsin B 1995
12 1-2 p. 130-
1 p.
artikel
181 Psychosocial stress of bronchial-carcinoma patients and their expectations of oncological indoor aftercare 1995
12 1-2 p. 160-
1 p.
artikel
182 Pulmonary function after sleeve lobectomy 1995
12 1-2 p. 141-
1 p.
artikel
183 Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer 1995
12 1-2 p. 143-144
2 p.
artikel
184 Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer 1995
12 1-2 p. 157-
1 p.
artikel
185 RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma 1995
12 1-2 p. 122-
1 p.
artikel
186 Re-assessment of acidic glycosphingolipids in small-cell-lung-cancer tissues and cell lines 1995
12 1-2 p. 125-
1 p.
artikel
187 Recent results and open questions of health hazards by radon with special consideration of the ‘Schneeberger lung disease’ 1995
12 1-2 p. 117-
1 p.
artikel
188 Reduced levels of topoisomerase IIα and IIβ in a multidrug-resistant lung-cancer cell line 1995
12 1-2 p. 143-
1 p.
artikel
189 Regulation of LAK ativity from pleural cavity lymphocytes and peripheral blood lymphocytes by pleural cavity macrophages in lung cancer patients without malignant effusion 1995
12 1-2 p. 132-
1 p.
artikel
190 Residental radon exposure and lung cancer — An epidemiological study of Norwegian municipalities 1995
12 1-2 p. 117-
1 p.
artikel
191 Retention index of thallium-201 single photon emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lung 1995
12 1-2 p. 133-
1 p.
artikel
192 Risk factors for lung cancer in Rio de Janeiro, Brazil: A case-control study 1995
12 1-2 p. 115-
1 p.
artikel
193 Role of DT-diaphorase as a determinant of sensitivity to mitomycin analogues in non-small cell lung cancer cell lines 1995
12 1-2 p. 144-
1 p.
artikel
194 Role of exercise stress testing in preoperative evaluation of patients for lung resection 1995
12 1-2 p. 136-
1 p.
artikel
195 Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer 1995
12 1-2 p. 157-
1 p.
artikel
196 Secretion of a latent, acid activatable cathepsin L precursor by human non- small cell lung cancer cell lines 1995
12 1-2 p. 126-
1 p.
artikel
197 Sera from some patients with antibody-associated paraneoplastic encephalomyelitis/sensory neuronopathy recognize the Ro-52K antigen 1995
12 1-2 p. 131-
1 p.
artikel
198 Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer Espinosa, E.
1995
12 1-2 p. 67-76
10 p.
artikel
199 Serum neuron-specific enolase in small cell lung cancer: A useful tumor marker? 1995
12 1-2 p. 131-
1 p.
artikel
200 Sex differences in clinicopathological features of peripheral T1 adenocarcinoma of the lung 1995
12 1-2 p. 138-
1 p.
artikel
201 Sex hormone receptors in non-small-cell lung cancer in human beings 1995
12 1-2 p. 135-
1 p.
artikel
202 Significance of the dosage of plasma carcinoembryonic antigen in small cell carcinoma 1995
12 1-2 p. 135-
1 p.
artikel
203 Small-cell lung cancer: Comparison to a weekly chemotherapy with drugs with a standard chemotherapy 1995
12 1-2 p. 150-
1 p.
artikel
204 Small cell lung cancer in the elderly 1995
12 1-2 p. 146-
1 p.
artikel
205 Small cell lung cancer treatment 1995
12 1-2 p. 159-
1 p.
artikel
206 Small cell lung cancer with paraneoplastic nephrotic syndrome 1995
12 1-2 p. 137-
1 p.
artikel
207 Small cell lung carcinoma cell lines express mRNA for calcitonin and alpha- and beta-calcitonin gene related peptides 1995
12 1-2 p. 119-
1 p.
artikel
208 Smoking and cancer: Smoking cessation 1995
12 1-2 p. 114-
1 p.
artikel
209 Smoking of hand-rolled cigarettes as a risk factor for small cell lung cancer in men: A case-control study from Uruguay 1995
12 1-2 p. 115-
1 p.
artikel
210 Spontaneous production of interleukin-8 by human lung cancer cells and its augmentation by tumor necrosis factor alpha and interleukin-1 at protein and mRNA levels 1995
12 1-2 p. 120-
1 p.
artikel
211 Spontaneous regression of small cell lung cancer 1995
12 1-2 p. 137-
1 p.
artikel
212 Subcutaneous heparin treatment increases survival in small cell lung cancer 1995
12 1-2 p. 152-
1 p.
artikel
213 Successful treatment of refractory extensive small cell lung cancer by oral etoposide 1995
12 1-2 p. 145-
1 p.
artikel
214 Superior sulcus tumors: Combined modality 1995
12 1-2 p. 157-
1 p.
artikel
215 Superior vena cava syndrome (SVCS) in small cell lung cancer - A prognostic factor? 1995
12 1-2 p. 130-131
2 p.
artikel
216 Surgery after radiochemotherapy for stage III lung cancer: Postoperative complications and late results 1995
12 1-2 p. 158-
1 p.
artikel
217 Surgery for stage IIIa-N2 non-small cell lung cancer 1995
12 1-2 p. 142-
1 p.
artikel
218 Surgical results and prognostic factors of pathologic N1 disease in non- small-cell carcinoma of the lung — Significance of N1 level: Lobar or hilar nodes 1995
12 1-2 p. 141-142
2 p.
artikel
219 Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments 1995
12 1-2 p. 151-
1 p.
artikel
220 The Alpha-Tocopherol, Beta-Carotene cancer prevention study in Finland 1995
12 1-2 p. 113-
1 p.
artikel
221 The clamshell incision: An improved approach to bilateral pulmonary and mediastinal tumor 1995
12 1-2 p. 141-
1 p.
artikel
222 The effects of chemotherapy and rhG-CSF on neutrophil functions in patients with pulmonary carcinoma 1995
12 1-2 p. 132-
1 p.
artikel
223 The EORTC QLQ-LC13: A modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials 1995
12 1-2 p. 139-
1 p.
artikel
224 The origin of isochromosomes and their significance in tumorigenesis of human lung cancer 1995
12 1-2 p. 125-
1 p.
artikel
225 The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer Buccheri, G.F.
1995
12 1-2 p. 45-58
14 p.
artikel
226 The plasminogen activation system and its role in lung cancer. A review Pappot, Helle
1995
12 1-2 p. 1-12
12 p.
artikel
227 Therapeutic evaluation of cisplatin, vindesine, and mitomycin C therapy in advanced non-small-cell lung cancer 1995
12 1-2 p. 149-
1 p.
artikel
228 The results of combination chemotherapy with etoposide, ifosfamide and cisplatin in patients with lung cancer (A preliminary report) 1995
12 1-2 p. 142-
1 p.
artikel
229 The role of chemotherapy in the treatment of stage III non-small-cell lung cancer (NSCLC) 1995
12 1-2 p. 148-149
2 p.
artikel
230 The treatment of non-small cell lung cancer: Current perspectives and controversies, future directions 1995
12 1-2 p. 158-
1 p.
artikel
231 The utility of bone marrow scintigraphy and magnetic resonance imaging for non-invasive diagnosis of bone marrow 1995
12 1-2 p. 137-
1 p.
artikel
232 Thirteen cases of subxiphoid pericardiotomy due to pericarditis associated with lung cancer 1995
12 1-2 p. 139-
1 p.
artikel
233 Three tumor-suppressor regions on chromosome 11p identified by high- resolution deletion mapping in human non-small-cell lung cancer 1995
12 1-2 p. 138-
1 p.
artikel
234 Tracheal obstruction after placement of a metal wire expandable stent (Wallstent) Koster, Mariska E.Y.
1995
12 1-2 p. 77-80
4 p.
artikel
235 Transforming growth factor-β1 inhibits TCDD-induced cytochrome P450IA1 expression in human lung cancer A549 cells 1995
12 1-2 p. 128-
1 p.
artikel
236 Transient neutropenia after intravenous injection of vindesine in patients with lung cancer 1995
12 1-2 p. 145-
1 p.
artikel
237 Treatment of lung cancer in 1994 1995
12 1-2 p. 159-
1 p.
artikel
238 Treatment-related deaths in small cell lung cancer trials: Can patients at risk be identified? 1995
12 1-2 p. 155-
1 p.
artikel
239 Two cases of resected lung cancer complicated with sarcoidosis 1995
12 1-2 p. 131-
1 p.
artikel
240 Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer 1995
12 1-2 p. 137-
1 p.
artikel
241 Vinorelbine monochemotherapy in non-small-cell lung cancer: Experience in patients with low performance status 1995
12 1-2 p. 148-
1 p.
artikel
242 VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer 1995
12 1-2 p. 155-
1 p.
artikel
                             242 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland